A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong Ye from the University of Texas San Antonio, has developed a new microfluidic-based biosensing platform that allows monitoring cellular secretion of monoclonal antibody in real time. This approach can make monoclonal antibody production more efficient, ultimately lowering manufacturing costs so these important biotherapeutics become more accessible to patients.
Novel label-free biosensing platform advances monoclonal antibody biomanufacturing
